We Are Breaking New Grounds In The Treatment Of Patients In Critical Care.

Alloksys Life Sciences is a pioneering company in the field of alkaline phosphatase-based medical treatments for critical care patients.

We Are Breaking New Grounds In The Treatment Of Patients In Critical Care.

Alloksys Life Sciences is a pioneering company in the field of alkaline phosphatase-based medical treatments for critical care patients.

Our Story

It all began with a strong belief in the potential of RESCAP® to revolutionize healthcare.

“In the early 1990s, the potential for using alkaline phosphatase (RESCAP®) to detoxify bacterial toxins was discovered. We proposed that this enzyme could be a simple treatment for various diseases and medical applications. As more scientists and clinicians came to share this belief in its potential, We were motivated to continue developing RESCAP®. Today, clinicians, investors, and employees continue to be encouraged by the potential of RESCAP® due to the abundance of pre-clinical and clinical research publications and our positive interim phase 2b results with RESCAP®”

What is RESCAP®

RESCAP® (rescuing alkaline phosphatase) is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP), naturally present in the body and part of the innate immune system (‘first line of defence’).

Technology and Research

RESCAP® is a therapeutic designed to expedite the recovery process for critical care patients. The use of RESCAP® has been shown to significantly  reduce the time it takes for patients in the ICU to stabilize and to lower the occurrence of severe complications, thereby improving their chances of recovery.

01

RESCAP® intervention has the potential to prevent inflammation.

04

Therefore, RESCAP® restores the normal homeostasis and thus will accelerate recovery of patients in the ICU.

02

RESCAP® intervention has the potential to prevent and restore leaky boundaries

03

RESCAP® intervention has the potential to prevent ischemia-induced organ damage

Technology and Research

RESCAP® is a therapeutic designed to expedite the recovery process for critical care patients. The use of RESCAP® has been shown to significantly  reduce the time it takes for patients in the ICU to stabilize and to lower the occurrence of severe complications, thereby improving their chances of recovery.

01

RESCAP® intervention has the potential to prevent inflammation.

02

RESCAP® intervention has the potential to prevent and restore leaky boundaries

03

RESCAP® intervention has the potential to prevent ischemia-induced organ damage

04

Therefore, RESCAP® restores the normal homeostasis and thus will accelerate recovery of patients in the ICU.

Clinical Trials

RESCAP® (rescuing alkaline phosphatase) is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP), naturally present in the body and part of the innate immune system (‘first line of defence’).

Clinical Trials

RESCAP

RESCAP® (rescuing alkaline phosphatase) is the proprietary name for our medication based on the enzyme alkaline phosphatase (AP), naturally present in the body and part of the innate immune system (‘first line of defence’).

Clinical Trials

RESCAP

Market Opportunity

Market Opportunity

Patient Benefits

The ideal patient for RESCAP® is someone who is undergoing critical care, such as cardiothoracic surgery, solid organ transplant surgery, burn wound trauma, or is experiencing acute ischemic injury or its subsequent complications like acute kidney injury and capillary leak symptoms. This includes patients who are looking for a treatment that can help speed up their recovery time, improve their chances of a successful outcome, and reduce the likelihood of peri- and post-surgical complications.
At Alloksys, we believe that every patient deserves the best possible care, and that’s why we’ve developed RESCAP®. Our goal is to help patients like you recover faster and more fully, so you can get back to the things you love most. Whether you’re a patient, a caretaker, or a healthcare professional, we’re here to help and support you every step of the way.

Our Team

The Alloksys team is committed to bringing RESCAP® to market and making it widely available for those who could benefit from it.

Ruud Brands, PhD

President

Herman Feil, PhD

CFO

Willem ppt

Willem Seinen, Prof., PhD

CSO

Ronald ppt

Ronald Oosting, PhD

Scientific Director

News and Updates

Contact Us

Please take out a moment to fill this form, and we will get back to you soon.